Director's Dealing • Oct 3, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Philip Slätis | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Commercial Director RX & International | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument |
Shares in Navamedic ASA (ISIN: NO0010205966) | |||
| Identification code | ISIN: NO0010205966 | ||||
| b) | Nature of the transaction | Subscription for shares and exercise of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 |
21.50 | 3,422 | |||
| Sum 0 |
0 | 0 | |||
| d) | Aggregated information - Aggregated volume - Aggregated price |
NOK 73,573 | Subscription for 3,422 shares pursuant to exercise of 3,422 subscription rights | ||
| e) | Date of the transaction | 2025-10-03 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name Tranbergkollen Invest AS |
|||
| 2 | Reason for the notification | |||
| a) | Position/status | Close associate to Astrid T. Bratvedt, Chief Scientific Officer in Navamedic ASA | ||
| b) | Initial notification /Amendment | Initial notification | ||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
|||
| a) | Business name | Navamedic ASA | ||
| b) | LEI code | 529900LKVQOR2SRUJU71 | ||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
|||
| a) | Description of the financial instrument/type of instrument Identification code |
Shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0010205966 |
||
| b) | Nature of the transaction | Subscription for shares and exercise of subscription rights | ||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) |
| NOK 0 |
21.50 | 25,000 | ||
| Sum 0 |
0 | 0 | ||
| d) | Aggregated information - Aggregated volume - Aggregated price |
Subscription for 25,000 shares pursuant to exercise of 25,000 subscription rights NOK 537,500 |
||
| e) | Date of the transaction | 2025-10-03 | ||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Jostein Davidsen | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Chairperson of the board of directors | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0010205966 |
|||
| b) | Nature of the transaction | Subscription for shares and exercise of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 |
21.50 | 17,116 | |||
| Sum 0 |
0 | 0 | |||
| d) | Aggregated information - Aggregated volume - Aggregated price |
Subscription for 17,116 shares pursuant to exercise of 17,116 subscription rights NOK 367,994 |
|||
| e) | Date of the transaction | 2025-10-03 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Jurs AS | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Close associate to Morten Jurs, board member of Navamedic ASA | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument |
Shares in Navamedic ASA (ISIN: NO0010205966) | |||
| Identification code | ISIN: NO0010205966 | ||||
| b) | Nature of the transaction | Subscription for shares and exercise of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 |
21.50 | 7,851 | |||
| Sum 0 |
0 | 0 | |||
| d) | Aggregated information - Aggregated volume - Aggregated price |
NOK 168,796.50 | Subscription for 7,851 shares pursuant to exercise of 7,851 subscription rights | ||
| e) | Date of the transaction | 2025-10-03 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name Soleglad Invest AS |
||||
| 2 | Reason for the notification | ||||
| a) | Position/status | ASA | Close associate to Kathrine Elisabeth Gamborg Andreassen, CEO of Navamedic | ||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument |
Shares in Navamedic ASA (ISIN: NO0010205966) | |||
| Identification code | ISIN: NO0010205966 | ||||
| b) | Nature of the transaction | Subscription for shares and exercise of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 |
21.50 | 23,260 | |||
| Sum 0 |
0 | 0 | |||
| d) | Aggregated information - Aggregated volume - Aggregated price |
Subscription for 23,260 shares pursuant to exercise of 23,260 subscription rights |
|||
| e) | Date of the transaction | NOK 500,090 2025-10-03 |
|||
| f) | Place of the transaction | XOFF – Outside a trading venue |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.